Vitality Watch

Dossier pubmed preclinical 22-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.

Key claim: Asb2 protects against heart failure by ubiquitin-mediated degradation of KIF11, restoring lysosomal distribution, autophagic flux, and mitochondrial homeostasis; restoring Asb2 or inhibiting KIF11 reverses age-related and pressure-overload cardiac remodeling in mice.

Abstract

BACKGROUND: Heart failure remains a leading cause of mortality globally, driven by persistent mitochondrial dysfunction and maladaptive cardiac hypertrophy. Although impaired autophagic flux contributes to cardiac deterioration, the precise molecular mechanisms are still unclear. The ubiquitin-proteasome system serves as a critical regulator linking protein ubiquitination to autophagic flux and mitochondrial homeostasis. Asb2 (ankyrin repeat-containing protein with suppressor of cytokine signaling box 2), a muscle-specific E3 ubiquitin ligase essential for embryonic cardiogenesis, is uncharacterized in adult cardiac homeostasis and disease pathogenesis. METHODS: Male mice with inducible cardiomyocyte-specific Asb2 knockout were generated to investigate Asb2’s role in cardiac remodeling. Adeno-associated virus 9-mediated cardiomyocyte-specific Asb2 overexpression and KIF11 (kinesin family member 11) downregulation were used in transverse aortic constriction-induced hypertrophy and aging models. RNA sequencing, metabolite profiling, and mass spectrometry were used to assess the molecular mechanism by which Asb2 regulates cardiac metabolism and hypertrophy. RESULTS: Asb2β expression was significantly reduced in multiple forms of human cardiomyopathy and in hypertrophic murine hearts. Inducible Asb2 deletion in adult male mice led to the spontaneous development of cardiac hypertrophy and heart failure, accompanied by progressive accumulation of dysfunctional mitochondria and metabolic dysregulation. Mechanistically, Asb2 deficiency impaired ubiquitin-mediated degradation of KIF11, causing aberrant peripheral lysosomal redistribution and disrupting autophagosome-lysosome fusion, which resulted in impaired late-stage autophagic flux and metabolic disturbances. Notably, therapeutic restoration of Asb2 expression via adeno-associated virus 9-mediated delivery attenuated pressure overload-induced and age-related cardiac hypertrophy and heart failure. Moreover, both genetic and pharmacological inhibition of KIF11 effectively restored autophagic flux and mitochondrial homeostasis, thereby reversing pathological cardiac remodeling in Asb2-deficient hearts and transverse aortic constriction-induced cardiac dysfunction. CONCLUSIONS: Asb2 is a novel regulator of mitochondrial quality control in cardiomyocytes via KIF11-mediated lysosomal redistribution. Targeting the Asb2-KIF11 axis may be a promising strategy for improving mitochondrial homeostasis and cardiomyocyte function in chronic heart failure.

Why this matters

This finding adds a specific mechanical-organellar layer to cardiac-aging biology: lysosome positioning inside cardiomyocytes — set by a kinesin (KIF11) whose turnover is controlled by an E3 ligase adaptor (Asb2) — is proposed as a rate-limiting step for autophagic flux and mitochondrial quality control in the aging and stressed heart. It creates a druggable node (KIF11, already targeted in oncology) linking two hallmarks (autophagy, mitochondrial dysfunction) in a tissue where preclinical rescue in mice has repeatedly failed to translate.

Source

Link

Briefing card

Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.
Stage: preclinical · pubmed · 22-sep-2026

Applies to preclinical cardiac-aging research; no human data yet supports repurposing KIF11 inhibitors for heart failure.

Asb2 protects against heart failure by ubiquitin-mediated degradation of KIF11, restoring lysosomal distribution, autophagic flux, and mitochondrial homeostasis; restoring Asb2 or inhibiting KIF11 reverses age-related and pressure-overload cardiac remodeling in mice.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1161/CIRCULATIONAHA.126.080625

build build 880 · 2bcef25 · 2026-11-18